Log in to save to my catalogue

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70756762

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant

About this item

Full title

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant

Publisher

London: Nature Publishing Group UK

Journal title

Nature clinical practice. Oncology, 2007-08, Vol.4 (8), p.491-495

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Isolated extramedullary relapse of acute myeloid leukemia after allogeneic transplantation is a rare phenomenon, which is not well understood. Owonikoko
et al
. describe the case of a patient with primary refractory acute myeloid leukemia who received chemotherapy treatment on protocol, salvage therapy, matched-unrelated-donor stem-cell trans...

Alternative Titles

Full title

Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_70756762

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70756762

Other Identifiers

ISSN

1743-4254,1759-4774

E-ISSN

1743-4262,1759-4782

DOI

10.1038/ncponc0899

How to access this item